GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.…
Industry Peers
Medical DevicesKey Statistics
About GE HealthCare Technologies (NASDAQ: GEHC)
›
GE HealthCare Technologies (NASDAQ: GEHC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 54,000 employees.
The shares were at 81.89 USD on 19 November 2026, up 10.5% over 52 weeks. Its 52-week range is 58.75 USD to 89.77 USD: the price is 8.8% below the high and 39.4% above the low.
At a market capitalisation of 37.03B USD, it trades at 17.3 times trailing earnings and 14.9 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 32% for GEHC. It pays a dividend yielding 0.19% (it pays out 3% of its earnings), against a median of 2.41% among the dividend payers in that peer group.
GE HealthCare Technologies reports return on equity of 20.1%, an operating margin of 13.8% and revenue up 7.2% year over year.
Its debt exceeds its cash by 7.58B USD, a debt-to-equity ratio of 1.01. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 88.25 USD is 7.8% above the current price. The next earnings report is expected on 3 February 2027.